Frontlight ResearchEarly access
Pancreatic cancer trials in China
326 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study of GV20-0251 in Advanced or Refractory Solid Tumors
- Where
- Chengdu
- Age
- 18 years and over
- People
- 10
- Run by
- West China Hospital
See details and how to joinNCT07106827 - No phaseNot yet taking people in ChinaStudy on Efficacy and Safety of VMAT Technique With Local Dose Escalation for Unresectable Pancreatic Cancer
- Where
- Chifeng
- Age
- 18 years to 76 years
- People
- 30
- Run by
- Chifeng Tumor Hospital
See details and how to joinNCT07242911 - Phase 3Taking peopleFirstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 292
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT07235930 - Phase 2Not yet taking people in ChinaAdebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer
- Where
- Nanjing
- Age
- 18 years to 80 years
- People
- 30
- Run by
- Jinling Hospital, China
See details and how to joinNCT06177522 - Phase 2Not yet taking people in ChinaA Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 300
- Run by
- Shenyang Sunshine Pharmaceutical Co., LTD.
See details and how to joinNCT07233850 - Early phase 1Taking peopleClinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 20
- Run by
- Ruijin Hospital
See details and how to joinNCT06496373 - Early phase 1Taking peopleClinical Study of 177Lu-CTR-FAPI In the Treatment of Patients With Advanced, Metastatic Solid Tumors
- Where
- Shanghai
- Age
- 18 years to 85 years
- People
- 4
- Run by
- Yan Xing
See details and how to joinNCT07229768 - Early phase 1Not yet taking people in ChinaA Clinical Study Evaluating the Safety, Tolerability, Preliminary Efficacy and Immunogenicity of a Tumor Vaccine Injection Targeting Stressinducible Proteins MICA/B in Combination With the AG Regimen in Patients With Metastatic Pancreatic Cancer
- Where
- Hunan
- Age
- 18 years and over
- People
- 13
- Run by
- The Third Xiangya Hospital of Central South University
See details and how to joinNCT07231094 - Phase 1Taking peopleCEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors
- Where
- Hefei
- Age
- 18 years and over
- People
- 108
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT07179692 - Early phase 1Taking peopleA Single-Arm Investigator-Initiated Tria (IIT) Evaluating the Safety and Preliminary Efficacy of Autologous Drug-Loaded Neutrophils (NeuMed) in Patients With Unresectable Pancreatic Cancer
- Where
- Xi’an
- Age
- 18 years to 70 years
- People
- 3
- Run by
- The First Affiliated Hospital of Air Force Medical University
See details and how to joinNCT07198659 - Phase 2Taking peopleIBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 64
- Run by
- Zhejiang University
See details and how to joinNCT06770439 - Phase 3Taking peopleA Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 602
- Run by
- Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT07079228 - Phase 2Taking peopleClinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms
- Where
- Nanjing, Shanghai, Suzhou, Wenzhou, Zhengzhou
- Age
- 18 years to 75 years
- People
- 80
- Run by
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT06767813 - No phaseTaking peopleMulticentric Database for Solid Pseudopapillary Neoplasm of the Pancreas
- Where
- Shanghai
- People
- 2,000
- Run by
- Fudan University
See details and how to joinNCT07183280 - Phase 1Taking peopleA Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 20
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT06500052 - No phaseNot yet taking people in ChinaClinical Application of PET Imaging Targeting GPA33 in Malignant Tumors
- Where
- Wuhan
- Age
- 18 years to 70 years
- People
- 56
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07172503 - No phaseTaking peoplePGHD-AI Intelligent Model for the Nutritional Assessment and Intervention of Patients After Radical Surgery for Pancreatic Cancer.
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 200
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07167264 - Phase 1Taking peopleA Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
- Where
- Zhengzhou
- Age
- 18 years to 75 years
- People
- 21
- Run by
- GONGCHU Biotechnology Co., Ltd
See details and how to joinNCT06508307 - Phase 1/2Taking peopleA Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
- Where
- Chongqing, Jinan, Shanghai
- Age
- 18 years to 89 years
- People
- 130 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06907043 - Phase 1/2Taking peopleA Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 18
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT06758544 - No phaseTaking peopleArtificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
- Where
- Jiaxing, Ningbo, Shanghai
- Age
- 50 years and over
- People
- 400,000
- Run by
- Changhai Hospital
See details and how to joinNCT07117045 - Phase 1Taking peopleThe Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients With Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC)
- Where
- Beijing
- Age
- 18 years and over
- People
- 18
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06861543 - No phaseNot yet taking people in ChinaXH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 12
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07114666 - Phase 2/3Taking peopleCisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 30
- Run by
- Fudan University
See details and how to joinNCT06095141 - Phase 2Taking peoplemFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 30
- Run by
- Fudan University
See details and how to joinNCT06149689